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Abstract
The aim of this study was to determine whether maternal exposure to persistent perfluoroalkyl 
substances (PFASs) affect the capability to breastfeed.
In two Faroese birth cohorts (N=1,130), concentrations of five PFASs were measured in maternal 
serum during pregnancy or two weeks after term. Duration of breastfeeding was assessed by 
questionnaire and clinical interview. In adjusted linear regression models, a doubling of maternal 
serum PFASs was associated with a reduction in duration of both total and exclusive 
breastfeeding, most pronounced for perfluorooctane sulfonic acid (PFOS) where a doubling was 
associated with a reduction in total breastfeeding of 1.4 (95% CI: 0.6; 2.1) months and 
perfluorooctanoic acid (PFOA) where a doubling was associated with a reduction in exclusive 
breastfeeding of 0.5 (0.3; 0.7) months. The associations were evident among both primiparous and 
multiparous women, and thus cannot be explained by confounding from previous breastfeeding.
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1. Introduction
Breastfeeding has many positive effects on the infant as well as the mother [1]. Thus, the 
World Health Organization (WHO) recommends that infants are breastfed exclusively for 
the first six months of life and partially up to two years or beyond [2]. However, globally 
only 38% of infants are exclusively breastfed as recommended [3].
Initiation and duration of breastfeeding is thought to depend mainly on individual choice and 
societal factors [4], but recent research shows that nearly half of the mothers in a US cohort 
study experienced early undesired weaning [5]. Inadequate milk supply is frequently 
reported to be one of the leading causes for early weaning [6-8]. Although the perception of 
inadequate milk supply is often attributed to social and psychological factors, insufficient 
supply may also be real and caused by physiological factors [9].
Still, little is known about the physiological reasons for insufficient milk production, and the 
focus has been on hormonal abnormalities, maternal disease and contraindications [10]. 
Persistent environmental chemicals could potentially result in endocrine disruption that 
could affect the hormonal processes responsible for maternal breast milk production. For 
example, dichlorodiphenyldichloroethylene (DDE) has been associated with reduced 
duration of breastfeeding in studies carried out in the United States [11] and in Mexico [12]. 
In the Mexican study, differences remained after censoring of women who ceased 
breastfeeding for known external causes. However, the associations were confined to those 
who had previously breastfed, which suggests that at least some of the effect could be a 
result of confounding from previous breastfeeding. Thus, women who had previously 
breastfed for a longer period would both have lowered their current DDE concentrations and 
be more likely to breastfeed longer again, as compared to women who had previously 
breastfed only shortly [12].
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Also of possible concern are the perfluoroalkyl substances (PFASs), a group of highly 
persistent chemicals frequently used in consumer products [13], and which are ubiquitously 
present in humans [14-16]. Duration of breastfeeding in Danish women was found to 
decrease with increasing serum-concentrations of PFASs, but since the findings were seen 
only in multiparous women, previous breastfeeding could have confounded the association 
[17].
Using data from two Faroese cohorts we aimed to examine whether exposure to the five 
most common PFASs was associated with the duration of breastfeeding among primiparous 
and multiparous women.
2. Methods
2.1 Study design
Two birth cohorts were formed in 1997–2000 [18-20] and in 2007-2009 [21] in the Faroe 
Islands. Located in the North Atlantic, the Faroe Islands is a self-governing marine 
community within the Danish kingdom. This Nordic population is approximately 50,000, 
rather homogenous, and has free access to health care, including obstetric care. The birth 
cohorts were formed to examine associations between environmental chemical exposures 
and adverse health outcomes. The hypothesis being tested in the present study was 
formulated after data collection, as triggered by a recently published study [17].
A blood sample was obtained from the mother between week 34 and 36 of pregnancy (older 
cohort) or two weeks after their term date (younger cohort). Background and medical 
information about the mother, the gestational period and the childbirth was recorded at 
recruitment and at subsequent follow-up. At age 5, parents of both cohorts filled out a 
questionnaire followed by an interview by a research nurse. The younger cohort additionally 
filled out a questionnaire followed by an interview at age 18 months in which information 
about breastfeeding (yes/no), duration of exclusive breastfeeding, and breastfeeding in 
addition to formula or other food sources (mixed breastfeeding) was obtained (in terms of 
number of months). Total duration of breastfeeding was calculated as the sum of exclusive 
and mixed breastfeeding. Information about total duration of breastfeeding was, however, 
replaced with information from the questionnaire at age 5 years if the mother stated that the 
child had been breast-fed for more than 18 months. In the older cohort, information about 
duration of total and exclusive (no other food) breastfeeding was obtained from the 5-year 
questionnaire only. The WHO definition of exclusive breastfeeding states that no other 
liquids (including water) and solids are given [22]. We did, however, not inquire about 
supplementation with water; only trace amounts of PFASs have been detected in Faroese 
water samples [23].
Information retrieved from the hospital records included maternal age (maternal birthday – 
child birthday), parity (zero/at least one previous birth), pregnancy smoking (none/any), 
pregnancy alcohol intake (none/any), pre-pregnancy body mass index (BMI: weight/
height2), education (none/any education above primary school), and employment (employed 
including maternity leave/unemployed, under education, home maker, early retirement or 
sick leave). Furthermore, in the younger cohort, more detailed information about education 
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was also obtained in a questionnaire to the mothers two weeks after their term date. If 
information about education was missing from the hospital records, we used information 
from the subsequent maternal questionnaire. Twins were excluded from our analyses.
Written informed consent was obtained from all women included in the study. The Faroese 
cohort study was performed in accordance with the Helsinki declaration and was approved 
by the Faroese ethical review committee and the institutional review board at Harvard T.H. 
Chan School of Public Health.
2.2 Exposure assessment
The five most common PFASs, i.e., perfluorohexane sulfonic acid (PFHxS), perfluorooctane 
sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), and 
perfluorodecanoic acid (PFDA) were measured in maternal serum along with p,p′-DDE and 
polychlorinated biphenyls (PCBs). Quantitation of PFAS was carried out by isotope dilution 
and online solid-phase extraction followed by analysis using high-pressure liquid 
chromatography with tandem mass spectrometry [24]. PFOS was quantified by integration 
of two adjacent peaks, which represent the branched isomers and the linear isomer. The limit 
of detection (LOD) was 0.03 ng/mL. Values below LOD were assumed to be 0.015 ng/mL. 
The accuracy of the method was assessed by regular participation in the German Quality 
Assessment program (G-EQUAS) organized by the German Society of Occupational 
Medicine. The between batch-imprecision during the analysis of the samples were <7.7% 
for the older cohort and <5.0% for the younger cohort.
DDE and PCB serum analyses were conducted as previously described [18, 24]. The 
accuracy for this analysis was also assessed by participation in the G-EQUAS program. Use 
of quality control samples verified that the results from the two cohorts were comparable. A 
simplified ΣPCB concentration was calculated as the sum of congeners CB-138, CB-153, 
and CB-180 multiplied by 2.
The population distribution of PFASs, DDE and ΣPCB concentrations is skewed to the right, 
and these measures were therefore log-transformed using log10 in order to reduce the 
influence of outlying values when they were used as predictors and to avoid violating model 
assumptions when performing analyses of associations with PFASs as the outcome.
2.3 Statistical analysis
Women who had not provided information about duration of breastfeeding or provided a 
blood sample for PFAS analysis were compared to those who had provided the information 
using unadjusted logistic regression models, and the two cohorts were compared with regard 
to exposures, outcomes and covariates using Wilcoxon's rank-sum test (continuous 
variables) or Chi squared test (categorical variables). Confounding was identified using a 
directed acyclic graph (DAG, Figure 1) based on existing literature about predictors for 
breastfeeding and pregnancy serum-PFAS concentrations. Maternal smoking [6, 7, 9], 
maternal alcohol intake [10], high maternal BMI [7, 9], low maternal age [6-9], low 
maternal education [6-9], maternal employment [6], and primiparity [6, 8] have all been 
associated with reduced duration of breastfeeding. These factors might also be associated 
with PFAS exposure [25-29], although only the association between higher parity and 
Timmermann et al. Page 4
Reprod Toxicol. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
reduced serum-PFAS concentrations is consistent across studies [25-27, 29]. Confounding 
was identified as backdoor paths between maternal serum-PFAS concentrations and 
breastfeeding [30], and these paths were blocked by conditioning on one of the variables on 
each path if information was available [31].
Since knowledge about sources of PFAS exposure is limited and results from existing 
studies of predictors are inconsistent [25-29], we also tested associations between potential 
confounding variables and the log-transformed serum-PFAS concentrations in linear 
regression models adjusted for cohort, and the estimates of association were converted to 
express the percent differences in serum-PFAS concentrations with a one-unit increase in the 
covariate.
Associations between maternal serum concentrations of each PFAS (log-transformed) and 
duration of total and exclusive breastfeeding were determined in linear regression models, 
and estimates from these models were converted to express the change in breastfeeding 
duration with a doubling of the serum-PFAS concentration. The assumption about a linear 
association between log-transformed serum-PFAS concentrations and breastfeeding was 
tested by tentatively including non-log-transformed serum-PFAS concentration measures. 
Furthermore, model residuals were inspected in graphs.
All analyses were adjusted for cohort. In addition, we performed adjusted association 
analyses, in which we included potential confounding variables as identified in the DAG. We 
also examined correlations between serum concentrations of DDE, ΣPCB and PFASs and 
tentatively adjusted the association models for serum concentrations of DEE and ΣPCB to 
determine if these exposures explained any association between serum-PFAS concentrations 
and breastfeeding duration. To further examine whether an association could be ascribed to 
confounding from previous breastfeeding, we tested interactions between parity and serum-
PFAS concentrations. Furthermore, we performed analyses testing for cohort differences to 
ascertain whether any results were confined to one of the cohorts. Finally, we performed 
sensitivity analyses in which we stratified the associations by parity or cohort rather than 
testing interactions to examine if this would change the estimates.
Although serum concentrations of different PFASs are correlated, we attempted to include 
all five PFASs in a single model, while removing insignificant PFASs using the backwards 
elimination approach.
To adjust for dependence between women being included twice, all regression analyses were 
performed with cluster-robust standard errors. All associations were tested in complete-case-
analyses, and all analyses were performed in Stata version 14.1 (StataCorp, College Station, 
TX, USA). A significance level of 0.05 was applied for detecting associations and 
interactions.
3. Results
A total of 1,130 mother-child dyads were included in the study. Twenty-five mothers were 
included once in both the older and the younger cohort, nine were included twice in the 
older cohort, and two were included twice in the younger cohort. The study thus 
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encompassed 640 mother-child dyads in the older and 490 in the younger cohort. Among 
these, 1,092 (97%) maternal blood samples were drawn in which PFASs were measured, and 
information about duration of total and exclusive breastfeeding was provided in 1,030 and 
1,029 (91%) dyads respectively. Women who provided information about breastfeeding were 
older, more likely to have an education beyond primary school and to have given birth 
previously, and they had lower serum concentrations of PFOA but higher serum 
concentrations of PFNA and PFDA. Those who provided a blood sample for PFAS analysis 
were more likely to have an education and a job and less likely to have consumed alcohol 
during pregnancy and deliver preterm (results not shown).
The distribution of maternal serum concentrations of all five PFASs differed between the 
two cohorts, with the median PFHxS, PFOS, PFOA, and PFDA being lower in the younger 
cohort, whereas the median PFNA was higher (Table 1). In the younger cohort, 14 mothers 
had serum PFHxS concentrations below LOD. PFOS, PFOA, PFNA and PFDA were 
detectable in all serum samples. The median duration of total and exclusive breastfeeding 
was 9 and 5 months, respectively, with no significant difference between the cohorts (Table 
1). In the older cohort, 1.5% did not breastfeed at all and 4.2% introduced other sources of 
nutrition from the beginning. In the younger cohort the corresponding figures were 3.3% and 
5.1%. Smoking and alcohol consumption were significantly less frequent in the younger 
cohort, and the mothers of the younger cohort were on average 5 months older when their 
child was born, as compared to the mothers of the older cohort. Mothers of the younger 
cohort were also more likely to have an education beyond primary school and more likely to 
have a job (Table 1).
When adjusting for cohort only, older women, and those employed, had higher serum-PFNA 
concentrations, and older age was also associated with higher serum-PFDA but lower serum-
PFOA concentrations (Table 2). Higher maternal BMI, pregnancy smoking, and pregnancy 
alcohol intake were associated with increased serum concentrations of PFOS, PFOA, and 
PFHxS respectively, and having given birth previously was associated with decreased serum 
concentrations of PFHxS and PFOA but increased serum-PFDA concentrations (Table 2). 
Finally, maternal education was associated with lower concentrations of PFOS, PFOA, 
PFNA, and PFDA (Table 2). As determined by identification of backdoor paths in the DAG, 
these factors were all taken into account when examining the association between maternal 
serum-PFAS concentrations and duration of breastfeeding.
We found a strong negative association between maternal serum-PFAS concentrations and 
duration of both total and exclusive breastfeeding (Table 3). No deviation from log-linearity 
was found in the associations between PFAS exposure and breastfeeding. Residual plots 
indicated a slightly right-skewed distribution of the residuals for total duration of 
breastfeeding, and we therefore repeated the analyses after a square root transformation of 
total duration of breastfeeding. This change produced normally distributed residuals and 
revealed similar p-values for the associations.
Adjusting for maternal parity, age, pre-pregnancy BMI, pregnancy alcohol intake, pregnancy 
smoking, education, employment, and cohort weakened the association between PFOA and 
total breastfeeding but strengthened the association between PFNA and PFDA and total 
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breastfeeding. Other associations were only affected to a very limited degree or not affected 
at all. Thus, a doubling of maternal serum PFOS, PFOA, and PFNA concentrations remained 
significantly associated with a reduction in duration of total and exclusive breastfeeding, and 
a doubling of maternal serum PFDA concentrations was now additionally associated with a 
reduction in total duration of breastfeeding (Table 3, Model 2). Serum concentrations of 
DDE and ΣPCB were weakly to moderately correlated to the PFASs, and adjusting for 
maternal serum concentrations of DDE or ΣPCB slightly weakened some of the associations 
but did not substantially change them (results not shown).
The results were not confined to multiparous women, since we found equally strong 
associations in each group when including an interaction-term between parity and serum-
PFAS concentrations in the analyses (Table 3, Model 3). Stratification by parity in most 
analyses resulted in estimates very similar to those obtained when performing interaction 
analyses, although the association between PFOA and total duration of breastfeeding was 
slightly attenuated among primiparous women, where a doubling of PFOA was associated 
with a reduction of 0.6 (95% CI: -1.7; 0.5) months.
Finally, differences between the two cohorts were not statistically significant at the 5% level, 
but a tendency was seen towards the association between serum-PFAS concentrations and 
total duration of breastfeeding being weaker in the less-exposed younger cohort, as 
compared to the older cohort (Table 3, Model 4). Stratifying the analyses by cohort rather 
than performing interactions did not change the associations.
When including all five PFASs in a single model, only PFOA was significantly associated 
with the duration of exclusive breastfeeding, while both PFOA and PFNA were significantly 
associated with the total duration of breastfeeding after backwards elimination of the other 
PFASs.
4. Discussion
In this study, we found that increased maternal serum-PFAS concentrations were associated 
with a significantly shorter duration of both exclusive and total breastfeeding. This in 
accordance with a recent U.S. study, which found significant associations between high 
serum-PFOA concentrations and increased risk of early termination of breastfeeding [32], 
and it agrees well with the overall findings in 1,400 women from the Danish National Birth 
Cohort, although the Danish findings were confined to multiparous women [17]. Questions 
have, however, been raised about the validity of the serum-PFAS measurements in the 
Danish National Birth Cohort [33], thus possibly explaining the inability of the study to 
detect associations among primiparous women. In order to eliminate any confounding from 
the duration of previous breastfeeding, we would have had to include this factor in our 
analyses. However, this information was not obtained in our study, but similar strong 
associations among primiparous and multiparous women would argue against confounding 
from previous breastfeeding having played a major role in our study.
The PFAS exposure among the Faroese women is similar to that of women elsewhere in 
Western countries examined in the same years. Thus, the mothers in the younger cohort had 
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median serum-PFAS concentrations very similar to those of Danish pregnant women 
examined in 2010-2012 [34] but lower than those of American pregnant women examined in 
2003-2006 [35]. The median serum-PFAS concentrations among the mothers in the older 
cohort were somewhat higher, but their median PFOS and PFOA serum concentrations were 
close to those of American pregnant women examined in 1999-2002 [29] and slightly lower 
than those of pregnant women in the Danish National Birth Cohort in 1996-2002 [17]. The 
differences in serum-PFAS concentrations and temporal trends between the two cohorts 
could be part of the reason why some of the associations between PFAS exposure and total 
duration of breastfeeding appeared weaker in the younger cohort, as compared to the older 
cohort.
In addition to differences in serum-PFAS concentrations, mothers in the younger cohort 
were also older, better educated, more likely to work, and less likely to consume alcohol and 
smoke during pregnancy all of which is line with the time trends in the Faroe Islands.
In mouse studies, PFAS exposure at serum concentration levels similar to elevated human 
exposures has been shown to delay the differentiation of the lactating gland in the exposed 
dam [36, 37], and in addition to direct effects on the dam, this animal model has also 
revealed that both in utero [36-38] and peripubertal [39] PFAS exposure might stunt the 
subsequent development of the mammary gland tissue in females, although results could 
depend on mouse strain [39]. Furthermore, PFOS exposure has been associated with 
significantly reduced serum concentrations of prolactin-family hormone in pregnant mice 
[40]. It therefore seems plausible that cumulated PFAS exposures affect the ability to lactate.
We adjusted our analyses for several potential confounders, all of which had limited impact 
on the associations. However, residual confounding may still be present. In addition to 
physiological factors, termination of breastfeeding is also thought to be dependent on 
individual choice and societal factors [4], as well as social and psychological factors [9]. 
Societal factors such as paid maternity leave are uniform within the Faroese community and 
are thus unlikely to have confounded the associations in our study. We did not have 
information on psychological factors or individual choice, such as wanting to terminate 
breastfeeding because of work, but these factors are unlikely to be associated with serum-
PFAS concentrations, and thus would seem unlikely to have confounded the observed 
associations between PFAS exposure and early termination of breastfeeding. As for social 
factors, some were included in our analyses, but additional factors might also be important. 
Although maternal ethnicity has been associated with initiation and duration of 
breastfeeding in other settings [6, 7, 9], the Faroese population is highly homogenous, and 
ethnicity was therefore not considered in our analyses. Of greater interest, the Faroese 
population is highly exposed to other environmental chemicals, which may also pass into 
breast milk to an extent that they might affect the children's health [41]. Adjustment for 
maternal serum concentrations of DDE and ΣPCB, however, did not remove the 
associations. Knowledge about harmful substances being transferred in breast milk could, 
however, conceivably have made some women choose to terminate breastfeeding earlier than 
otherwise planned, but since the women in our study were unaware of their own exposure to 
all of the environmental chemicals, this factor is also an unlikely confounder.
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Some sources of imprecision may play a role. Thus, blood samples, in which PFASs were 
measured, were obtained at different time points in the two cohorts. Maternal serum-PFAS 
concentrations have been found to decline during pregnancy [27, 42], but serum-PFAS 
concentrations measured in the third trimester were highly correlated with serum-PFAS 
concentrations measured three weeks after delivery [42]. Timing of blood sampling is 
therefore unlikely to have affected our results, especially as all analyses were adjusted for 
cohort to account for any systematic differences in serum-PFAS concentrations between the 
cohorts. Furthermore, all serum samples were measured at the same laboratory with a 
documented record of excellent quality.
Some women may choose to terminate breastfeeding for other reasons than diminished milk 
production, which makes duration of breastfeeding less appropriate as a valid proxy measure 
for the capability to breastfeed, and any misclassification could possibly have resulted in an 
underestimation of the true association between PFAS exposure and the capability to 
breastfeed. Recall of breastfeeding duration may also involve some degree of imprecision 
and thus a loss of power, but since the maternal serum-PFAS concentrations were unknown 
to the women, differential misclassification is highly unlikely.
Women who did not provide information about breastfeeding had higher PFOS and lower 
PFNA and PFDA concentrations. We cannot exclude the possibility of selection bias, but 
any bias would likely weaken some associations between PFASs and breastfeeding while 
strengthening others, and since data was only missing for a minority of women, the 
associations found in our study are unlikely to have been caused by selection bias.
PFAS exposure is considered a public health concern for other reasons as well. Thus, 
maternal PFAS burdens can be transferred to the infant through breast milk [43], and PFAS 
exposure during infancy may lead to adverse health effects [16]. Studies on the benefits of 
long durations of breastfeeding therefore ought to consider the balance between nutritional 
and psychological benefits to the child and the possible toxicity from increased transfer of 
toxicants via human milk. Even if long-term breastfeeding is recommended, the adverse 
effects on lactation may make this difficult or impossible for some women. Our findings, in 
concert with other evidence, suggest that exposure to environmental chemicals, such as the 
PFASs, might interfere with women's ability to lactate in accordance with health 
recommendations. Although additional studies would be desirable, current knowledge on 
associations between environmental chemicals and the capability to lactate should be 
considered when assessing the causes of short breastfeeding duration.
4. Conclusions
Increased maternal serum-PFAS concentrations are associated with a decreased duration of 
breastfeeding. The results are not confined to multiparous women and are unlikely to be 
explained by confounding from maternal age, education, employment, and factors related to 
health behavior. This association may be due to deficient lactation caused by endocrine 
disruption effects and suggests that exposure to environmental chemicals should be taken 
into account when assessing the causes for early weaning.
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BMI Body mass index
DDE Dichlorodiphenyldichloroethylene
DAG Directed acyclic graph
LOD Limit of detection
PFAS Perfluoroalkyl substance
PFDA Perfluorodecanoic acid
PFHxS Perfluorohexane sulfonic acid
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PFNA Perfluorononanoic acid
PFOS Perfluorooctane sulfonic acid
PFOA Perfluorooctanoic acid
PCB Polychlorinated biphenyl
WHO World Health Organization
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Highlights
• Elevated maternal PFAS exposure is associated with reduced breastfeeding 
duration
• A doubled serum-PFOS reduced total duration of breastfeeding by 1.4 months
• A doubled serum-PFOA reduced exclusive breastfeeding duration by 0.5 
months
• Associations were seen among both primiparous and multiparous women
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Figure 1. Association between maternal serum-PFAS and duration of breastfeeding
Hypothesized causal associations and potential confounding paths are depicted in a Directed 
Acyclic Graph (DAG).
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